Insider Transactions in Q4 2020 at Hca Healthcare, Inc. (HCA)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 24
2020
|
Deborah M Reiner SVP - Mktg. & Communications |
SELL
Open market or private sale
|
Direct |
1,266
-18.76%
|
$196,230
$155.0 P/Share
|
|
Nov 17
2020
|
Deborah M Reiner SVP - Mktg. & Communications |
SELL
Payment of exercise price or tax liability
|
Direct |
5,771
-46.09%
|
$882,963
$153.03 P/Share
|
|
Nov 17
2020
|
Deborah M Reiner SVP - Mktg. & Communications |
BUY
Exercise of conversion of derivative security
|
Direct |
7,037
+18.94%
|
$752,959
$107.39 P/Share
|
|
Nov 16
2020
|
Deborah M Reiner SVP - Mktg. & Communications |
SELL
Open market or private sale
|
Direct |
5,078
-48.08%
|
$766,778
$151.75 P/Share
|
|
Nov 16
2020
|
J William Morrow SVP - Finance and Treasurer |
SELL
Bona fide gift
|
Direct |
117
-8.62%
|
-
|
|
Nov 16
2020
|
J William Morrow SVP - Finance and Treasurer |
SELL
Open market or private sale
|
Direct |
7,868
-85.28%
|
$1,188,068
$151.75 P/Share
|
|
Nov 16
2020
|
P. Martin Paslick SVP and CIO |
SELL
Open market or private sale
|
Direct |
3,770
-100.0%
|
$569,270
$151.75 P/Share
|
|
Nov 16
2020
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
24,257
-51.97%
|
$3,662,807
$151.82 P/Share
|
|
Nov 16
2020
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
44,750
+48.95%
|
$1,655,750
$37.18 P/Share
|
|
Nov 13
2020
|
J William Morrow SVP - Finance and Treasurer |
SELL
Open market or private sale
|
Direct |
1,350
-12.76%
|
$201,150
$149.75 P/Share
|
|
Nov 13
2020
|
P. Martin Paslick SVP and CIO |
SELL
Open market or private sale
|
Direct |
319
-7.8%
|
$47,531
$149.47 P/Share
|
|
Nov 13
2020
|
P. Martin Paslick SVP and CIO |
BUY
Bona fide gift
|
Indirect |
127,999
+50.0%
|
-
|
|
Nov 13
2020
|
P. Martin Paslick SVP and CIO |
SELL
Bona fide gift
|
Indirect |
63,999
-100.0%
|
-
|
|
Nov 13
2020
|
P. Martin Paslick SVP and CIO |
SELL
Bona fide gift
|
Direct |
64,000
-93.99%
|
-
|
|
Nov 13
2020
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
SELL
Open market or private sale
|
Direct |
17,002
-89.82%
|
$2,533,298
$149.5 P/Share
|
|
Nov 13
2020
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
BUY
Bona fide gift
|
Indirect |
7,802
+11.89%
|
-
|
|
Nov 13
2020
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
SELL
Bona fide gift
|
Indirect |
7,802
-100.0%
|
-
|
|
Nov 12
2020
|
P. Martin Paslick SVP and CIO |
BUY
Bona fide gift
|
Direct |
64,000
+48.45%
|
-
|
|
Nov 12
2020
|
P. Martin Paslick SVP and CIO |
SELL
Bona fide gift
|
Indirect |
64,000
-50.0%
|
-
|
|
Nov 11
2020
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
BUY
Bona fide gift
|
Indirect |
15,604
+30.95%
|
-
|
|
Nov 11
2020
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
SELL
Bona fide gift
|
Direct |
15,604
-25.89%
|
-
|
|
Nov 10
2020
|
Jon M Foster EVP and COO |
BUY
Bona fide gift
|
Indirect |
34,039
+43.6%
|
-
|
|
Nov 10
2020
|
Jon M Foster EVP and COO |
SELL
Bona fide gift
|
Indirect |
34,039
-100.0%
|
-
|
|
Nov 10
2020
|
Charles J Hall Group President |
SELL
Open market or private sale
|
Direct |
6,536
-3.16%
|
$1,006,544
$154.46 P/Share
|
|
Nov 09
2020
|
P. Martin Paslick SVP and CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,911
-59.11%
|
$868,917
$147.32 P/Share
|
|
Nov 09
2020
|
P. Martin Paslick SVP and CIO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$470,000
$47.97 P/Share
|
|
Nov 09
2020
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
20,498
-37.25%
|
$3,013,206
$147.32 P/Share
|
|
Nov 09
2020
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+40.53%
|
$1,387,500
$37.18 P/Share
|
|
Nov 09
2020
|
Jane D. Englebright SVP and Chief Nursing Officer |
SELL
Open market or private sale
|
Direct |
3,490
-29.07%
|
$520,010
$149.75 P/Share
|
|
Nov 09
2020
|
P. Martin Paslick SVP and CIO |
SELL
Open market or private sale
|
Direct |
3,948
-100.0%
|
$584,304
$148.07 P/Share
|
|
Nov 09
2020
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
SELL
Open market or private sale
|
Direct |
5,531
-23.98%
|
$813,057
$147.36 P/Share
|
|
Nov 06
2020
|
Bill B Rutherford CFO and EVP |
SELL
Bona fide gift
|
Direct |
250
-1.34%
|
-
|
|
Nov 05
2020
|
Jennifer Berres SVP & Chief Human Res. Officer |
SELL
Open market or private sale
|
Direct |
3,472
-71.63%
|
$482,608
$139.19 P/Share
|
|
Nov 05
2020
|
Jane D. Englebright SVP and Chief Nursing Officer |
SELL
Open market or private sale
|
Direct |
1,745
-19.96%
|
$242,555
$139.5 P/Share
|
|
Nov 05
2020
|
Charles J Hall Group President |
SELL
Open market or private sale
|
Direct |
15,000
-6.52%
|
$2,085,000
$139.36 P/Share
|
|
Nov 05
2020
|
P. Martin Paslick SVP and CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,052
-60.52%
|
$829,124
$137.56 P/Share
|
|
Nov 05
2020
|
P. Martin Paslick SVP and CIO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$470,000
$47.97 P/Share
|
|
Nov 05
2020
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,969
-23.21%
|
$954,753
$137.56 P/Share
|
|
Nov 05
2020
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+29.39%
|
$462,500
$37.18 P/Share
|
|
Nov 05
2020
|
Bill B Rutherford CFO and EVP |
SELL
Open market or private sale
|
Direct |
36,250
-66.02%
|
$5,038,750
$139.33 P/Share
|
|
Nov 05
2020
|
Bill B Rutherford CFO and EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
11,250
+9.74%
|
$236,250
$21.73 P/Share
|
|
Nov 04
2020
|
Jon M Foster EVP and COO |
BUY
Bona fide gift
|
Indirect |
68,078
+46.8%
|
-
|
|
Nov 04
2020
|
Jon M Foster EVP and COO |
SELL
Bona fide gift
|
Direct |
68,078
-75.0%
|
-
|
|
Nov 03
2020
|
Samuel N Hazen CEO |
SELL
Open market or private sale
|
Direct |
121,875
-11.42%
|
$16,453,125
$135.85 P/Share
|
|
Nov 03
2020
|
Samuel N Hazen CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
227,540
-36.83%
|
$30,945,440
$136.09 P/Share
|
|
Nov 03
2020
|
Samuel N Hazen CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
557,125
+22.45%
|
$13,371,000
$24.18 P/Share
|
|
Nov 03
2020
|
Bill B Rutherford CFO and EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
34,061
-43.83%
|
$4,632,296
$136.09 P/Share
|
|
Nov 03
2020
|
Bill B Rutherford CFO and EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
66,575
+31.28%
|
$1,997,250
$30.07 P/Share
|
|
Nov 03
2020
|
P. Martin Paslick SVP and CIO |
SELL
Open market or private sale
|
Direct |
1,771
-100.0%
|
$235,543
$133.5 P/Share
|
|
Nov 02
2020
|
Sandra L. Morgan SVP-Provider Relations |
SELL
Open market or private sale
|
Direct |
5,030
-47.33%
|
$638,810
$127.75 P/Share
|